Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

58.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration of point of care ultrasound into undergraduate medical education at Texas Tech University Health Sciences Center school of medicine: a 6 year review.

BMC medical education·2024
Same author

New Indian species of Dacus Fabricius (Diptera: Tephritidae: Dacinae: Dacini) similar to Dacus crabroniformis (Bezzi), endemic to the Western Ghats and Northeastern Himalayas.

Zootaxa·2024
Same author

Lipoxygenase-generated hydroperoxides account for the nonphysiological features of ethylene formation from 1-aminocyclopropane-1-carboxylic acid by microsomal membranes of carnations.

Planta·2013
Same author

A retrospective look at replacing face-to-face embryology instruction with online lectures in a human anatomy course.

Anatomical sciences education·2013
Same author

Ecdysone receptor and ultraspiracle proteins are tyrosine phosphorylated during adult development of silkmoths.

Insect biochemistry and molecular biology·2011
Same author

Retrieval of a migrated Polyflex stent--a novel technique.

Endoscopy·2009

Related Experiment Video

Updated: May 7, 2026

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
05:36

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles

Published on: October 4, 2024

2.2K

Tebufenozide disrupts ovarian development and function in silkmoths.

S Sridhara1, Vaughan H Lee

  • 1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Insect Biochemistry and Molecular Biology
|October 15, 2013
PubMed
Summary

Tebufenozide, a non-steroidal ecdysteroid agonist, hinders silkmoth ovarian development and egg production by disrupting follicular tissues and inhibiting vitellogenin uptake. This suggests dual inhibitory mechanisms are involved in its effects on oogenesis.

Keywords:
20-Hydroxyecdysone20.hydroxyecdysone20EDMSOEcRHlLpOvaryPTTHPTUSilkmothsTebufenozideUSPVgVitellogenindimethyl sulfoxideecdysone receptorhemolymphlipophorin or arylphorinphenylthioureaprothoracicotrophic hormoneultraspiraclevitellogenin or vitellin

More Related Videos

Functional Manipulation of Maternal Gene Products Using In Vitro Oocyte Maturation in Zebrafish
10:39

Functional Manipulation of Maternal Gene Products Using In Vitro Oocyte Maturation in Zebrafish

Published on: April 22, 2017

14.3K
Microsurgical Obstruction of Testes Fusion in Spodoptera litura
03:38

Microsurgical Obstruction of Testes Fusion in Spodoptera litura

Published on: July 16, 2021

2.0K

Related Experiment Videos

Last Updated: May 7, 2026

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
05:36

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles

Published on: October 4, 2024

2.2K
Functional Manipulation of Maternal Gene Products Using In Vitro Oocyte Maturation in Zebrafish
10:39

Functional Manipulation of Maternal Gene Products Using In Vitro Oocyte Maturation in Zebrafish

Published on: April 22, 2017

14.3K
Microsurgical Obstruction of Testes Fusion in Spodoptera litura
03:38

Microsurgical Obstruction of Testes Fusion in Spodoptera litura

Published on: July 16, 2021

2.0K

Area of Science:

  • Insect endocrinology
  • Developmental biology
  • Reproductive physiology

Background:

  • 20-hydroxyecdysone (20E) is crucial for adult silkmoth development and egg production.
  • Tebufenozide is a non-steroidal ecdysteroid agonist used to study hormonal effects.

Purpose of the Study:

  • To investigate the effects of tebufenozide on silkmoth ovarian development and egg formation.
  • To elucidate the mechanisms underlying tebufenozide's impact on oogenesis.

Main Methods:

  • Administering tebufenozide to female silkmoth pharate adults.
  • Assessing epidermal tissue development, ovarian growth, and egg formation.
  • Analyzing RNA and protein synthesis, vitellogenin (Vg) accumulation in ovaries and hemolymph.
  • Measuring hemolymph volumes.

Main Results:

  • Tebufenozide induced full epidermal development but minimal ovarian growth and egg formation.
  • Disruption of follicular epithelium, nurse cell damage, and inhibited oogenesis were observed.
  • Reduced RNA/protein synthesis and vitellogenin uptake in ovaries occurred.
  • Hemolymph vitellogenin levels remained constant, suggesting egg development involves uptake of multiple hemolymph proteins.

Conclusions:

  • Tebufenozide exhibits biphasic inhibitory actions on silkmoth ovaries through dual mechanisms.
  • These mechanisms involve ecdysteroid antagonist action and another function during egg formation.
  • 20E cannot overcome the ovarian growth inhibitory effects of tebufenozide.